Literature DB >> 15063726

Interaction of amiloride and one of its derivatives with Vpu from HIV-1: a molecular dynamics simulation.

V Lemaitre1, R Ali, C G Kim, A Watts, W B Fischer.   

Abstract

Vpu is an 81-residue membrane protein, with a single transmembrane segment that is encoded by HIV-1 and is involved in the enhancement of virion release via formation of an ion channel. Cyclohexamethylene amiloride (Hma) has been shown to inhibit ion channel activity. In the present 12-ns simulation study a putative binding site of Hma blockers in a pentameric model bundle built of parallel aligned helices of the first 32 residues of Vpu was found near Ser-23. Hma orientates along the channel axis with its alkyl ring pointing inside the pore, which leads to a blockage of the pore.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063726     DOI: 10.1016/S0014-5793(04)00251-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Authors:  Raphaël Vigan; Stuart J D Neil
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers.

Authors:  Jun-Xia Lu; Simon Sharpe; Rodolfo Ghirlando; Wai-Ming Yau; Robert Tycko
Journal:  Protein Sci       Date:  2010-10       Impact factor: 6.725

3.  Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations.

Authors:  Bing Zhang; Vincent B C Tan; Kian Meng Lim; Tong Earn Tay; Shulin Zhuang
Journal:  J Mol Model       Date:  2006-06-13       Impact factor: 1.810

4.  Molecular dynamics simulations on the inhibition of cyclin-dependent kinases 2 and 5 in the presence of activators.

Authors:  Bing Zhang; Vincent B C Tan; Kian Meng Lim; Tong Earn Tay
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

Review 5.  HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms.

Authors:  Amy Andrew; Klaus Strebel
Journal:  Mol Aspects Med       Date:  2010-09-19

6.  Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs.

Authors:  Sang Ho Park; Stanley J Opella
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

7.  Novel Acylguanidine-Based Inhibitor of HIV-1.

Authors:  Philip Mwimanzi; Ian Tietjen; Scott C Miller; Aniqa Shahid; Kyle Cobarrubias; Natalie N Kinloch; Bemuluyigza Baraki; Jonathan Richard; Andrés Finzi; David Fedida; Zabrina L Brumme; Mark A Brockman
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

8.  Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy.

Authors:  Eike Steinmann; Thomas Pietschmann
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.818

9.  Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.

Authors:  Mingyu Lv; Jiawen Wang; Xiaodan Wang; Tao Zuo; Yingzi Zhu; Wei Kong; Xianghui Yu
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

10.  Molecular dynamics simulations reveal the HIV-1 Vpu transmembrane protein to form stable pentamers.

Authors:  Siladitya Padhi; Nabab Khan; Shahid Jameel; U Deva Priyakumar
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.